DaVita Inc. Q3 2024 10-Q: Debt Maturities and Financials
Ticker: DVA · Form: 10-Q · Filed: 2024-10-29T00:00:00.000Z
Sentiment: neutral
Topics: debt, financials, 10-Q, healthcare
TL;DR
DaVita's Q3 10-Q shows debt due through 2027, with rates up to 4.50%.
AI Summary
DaVita Inc. filed its 10-Q for the period ending September 30, 2024. The filing details financial information, including various debt instruments with maturity dates ranging from December 31, 2025, to December 31, 2027, and interest rates between 3.75% and 4.50%. The company's fiscal year ends on December 31st.
Why It Matters
This filing provides insight into DaVita's debt structure and upcoming financial obligations, which are crucial for investors assessing the company's financial health and risk.
Risk Assessment
Risk Level: medium — The filing details significant debt obligations, which can pose a risk if the company's cash flow is insufficient to meet repayment schedules.
Key Numbers
- 3.75% — Minimum Interest Rate (On certain debt instruments)
- 4.50% — Maximum Interest Rate (On certain debt instruments)
- 2025-12-31 — Earliest Debt Maturity (For a significant portion of reported debt)
- 2027-12-31 — Latest Debt Maturity (For a significant portion of reported debt)
Key Players & Entities
- DAVITA INC. (company) — Filer
- 20240930 (date) — Period of Report
- 20241029 (date) — Filing Date
- 3.75% (dollar_amount) — Interest Rate on Debt
- 4.50% (dollar_amount) — Interest Rate on Debt
- December 31, 2025 (date) — Debt Maturity Date
- December 31, 2027 (date) — Debt Maturity Date
FAQ
What is the total amount of debt maturing by the end of 2025?
The filing indicates debt maturing on 12/31/2025 with principal amounts of $1,000,000 and $750,000, among others.
What are the interest rates on DaVita's debt?
Interest rates vary, with examples including 3.75%, 4.00%, and 4.50% on different debt tranches.
When does DaVita's fiscal year end?
DaVita's fiscal year ends on December 31st.
What is the filing period for this 10-Q?
The filing covers the period ending September 30, 2024.
What was DaVita Inc. formerly known as?
DaVita Inc. was formerly known as DaVita Healthcare Partners Inc. and Total Renal Care Holdings Inc.
From the Filing
0000927066-24-000179.txt : 20241029 0000927066-24-000179.hdr.sgml : 20241029 20241029170429 ACCESSION NUMBER: 0000927066-24-000179 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 79 CONFORMED PERIOD OF REPORT: 20240930 FILED AS OF DATE: 20241029 DATE AS OF CHANGE: 20241029 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DAVITA INC. CENTRAL INDEX KEY: 0000927066 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 510354549 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-14106 FILM NUMBER: 241406552 BUSINESS ADDRESS: STREET 1: 2000 16TH STREET CITY: DENVER STATE: CO ZIP: 80202 BUSINESS PHONE: 310-536-2668 MAIL ADDRESS: STREET 1: 2000 16TH STREET CITY: DENVER STATE: CO ZIP: 80202 FORMER COMPANY: FORMER CONFORMED NAME: DAVITA HEALTHCARE PARTNERS INC. DATE OF NAME CHANGE: 20121107 FORMER COMPANY: FORMER CONFORMED NAME: DAVITA INC DATE OF NAME CHANGE: 20001005 FORMER COMPANY: FORMER CONFORMED NAME: TOTAL RENAL CARE HOLDINGS INC DATE OF NAME CHANGE: 19950524 10-Q 1 dva-20240930.htm 10-Q dva-20240930 false 2024 Q3 0000927066 12/31 0.001 5,000 — 0.001 450,000 82,624 88,824 90,132 88,824 not Base + 1.75% Base + 1.75% 1,000,000 3.75 6/30/2024 12/31/2025 1,000,000 6/30/2024 12/31/2025 1,000,000 2024-06-30 12/31/2025 500,000 2024-06-30 12/31/2026 250,000 4.50 2024-12-31 12/31/2025 750,000 4.00 2024-12-31 12/31/2026 1,000,000 2025-12-31 12/31/2027 750,000 2025-12-31 12/31/2027 1,533,635 1,828,245 within 45 business days of notice five years xbrli:shares iso4217:USD iso4217:USD xbrli:shares dva:segment xbrli:pure dva:Clinic 0000927066 2024-01-01 2024-09-30 0000927066 2024-10-25 0000927066 2024-07-01 2024-09-30 0000927066 2023-07-01 2023-09-30 0000927066 2023-01-01 2023-09-30 0000927066 2024-09-30 0000927066 2023-12-31 0000927066 2022-12-31 0000927066 2023-09-30 0000927066 dva:TemporaryEquityRedeemableNoncontrollingInterestsMember 2024-06-30 0000927066 us-gaap:CommonStockMember 2024-06-30 0000927066 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0000927066 us-gaap:RetainedEarningsMember 2024-06-30 0000927066 us-gaap:TreasuryStockCommonMember 2024-06-30 0000927066 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-06-30 0000927066 us-gaap:ParentMember 2024-06-30 0000927066 us-gaap:NoncontrollingInterestMember 2024-06-30 0000927066 dva:TemporaryEquityRedeemableNoncontrollingInterestsMember 2024-07-01 2024-09-30 0000927066 us-gaap:RetainedEarningsMember 2024-07-01 2024-09-30 0000927066 us-gaap:ParentMember 2024-07-01 2024-09-30 0000927066 us-gaap:NoncontrollingInterestMember 2024-07-01 2024-09-30 0000927066 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-07-01 2024-09-30 0000927066 us-gaap:CommonStockMember 2024-07-01 2024-09-30 0000927066 us-gaap:AdditionalPaidInCapitalMember 2024-07-01 2024-09-30 0000927066 us-gaap:TreasuryStockCommonMember 2024-07-01 2024-09-30 0000927066 dva:TemporaryEquityRedeemableNoncontrollingInterestsMember 2024-09-30 0000927066 us-gaap:CommonStockMember 2024-09-30 0000927066 us-gaap:AdditionalPaidInCapitalMember 2024-09-30 0000927066 us-gaap:RetainedEarningsMember 2024-09-30 0000927066 us-gaap:TreasuryStockCommonMember 2024-09-30 0000927066 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-09-30 0000927066 us-gaap:ParentMember 2024-09-30 0000927066 us-gaap:NoncontrollingInterestMember 2024-09-30 0000927066 dva:TemporaryEquityRedeemableNoncontrollingInterestsMember 2023-12-31 0000927066 us-gaap:CommonStockMember 2023-12-31 0000927066 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0000927066 us-gaap:RetainedEarningsMember 2023-12-31 0000927066 us-gaap:TreasuryStockCommonMember 2023-12-31 0000927066 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0000927066 us-gaap:ParentMember 2023-12-31 0000927066 us-gaap:NoncontrollingInterestMember 2023-12-31 0000927066 dva:TemporaryEquityRedeemableNoncontrollingIntere